Effectiveness and Safety of Pharmacopunture Therapy for Chronic Low Back Pain: A Pragmatic Randomized Controlled Trial
CompletedNot applicableNCT04833309
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a multi-center, 2-arm parallel pragmatic randomized controlled trial that will compare pharmacopuncture therapy with physical therapy for chronic low back pain.
Study details
- Official title
- Effectiveness and Safety of Pharmacopunture Therapy for Chronic Low Back Pain: A Pragmatic Randomized Controlled Trial
- Conditions
- Interventions
- Procedure: pharmacopuncture therapy
- Procedure: physical therapy
- Sponsor
- Jaseng Medical Foundation
- Collaborators
- Korea Institute of Oriental Medicine
- Start date
- 2021-06-10
- Primary completion
- 2022-02-26
- Sex
- All
- Age range
- from 19 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 4
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. low back pain for more than 6 months 2. Numeric rating scale (NRS) score for low back pain 5 or more 3. 19-70 years old 4. participants who agreed and signed informed consent form Exclusion Criteria: 1. Spine metastasis of cancer, acute fracture of spine, or spine dislocation 2. Progressive neurologic deficits or severe neurologic deficits 3. Soft tissue diseases that can induce low back pain (ie. cancer, fibromyalgia, rheumatoid arthritis, gout, etc) 4. Presence of chronic underlying disease which can interfere the efficacy or interpretation (ie. stroke, myocardial infarct, kidney disease, dementia, diabetic neuropathy, epilepsy, etc) 5. Concurrent use of steroids, immunosuppressants, or psychotropic medications 6. Hemorrhagic disease, severe diabetes or taking anticoagulant drug 7. Participants who took NSAIDs or pharmacopuncture within 1 week 8. Pregnant or lactating women 9. Participants who had undergone lumbar surgery within 3 months 10. Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial 11. Participants who can not write informed consent 12. Participants who is difficult to participate in the trial according to investigator's decision
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04833309